Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Radiopharmaceutical Chemistry Track

  • You have access
    Biodistribution and targeted radiotherapy of [(Lys40(Ahx-[111In-DTPA])]-Exendin-4 in a Glucagon-like-Peptide-1 receptor-positive, tumor-bearing transgenic mouse model
    Damian Wild, Andreas Wicki, Daniel Storch, Martin Behe, Gerhard Christofori, JeanClaude Reubi and Helmut Maecke
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 93P;
  • You have access
    Biodistribution of [18F]2-dexoy-2-fluoro-β-D-allose (2-FDβA): A PET imaging agent for the detection of breast tumor
    Raman Chirakal, Troy Farncombe, Rezwan Ashique, Chantal Saab, Karen Gulenchyn, Tracey Truman and Renee Labiris
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 90P;
  • You have access
    Synthesis of N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC, its biodistribution, and use in imaging prostate cancer xenografts
    Ronnie Mease, C Dusich, C Foss, H Ravert, R Dannals, J Seidel, J Fox, A Kozikowski and M Pomper
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 89P;
  • You have access
    Synthesis, in vivo biodistribution and microPET imaging studies in nu/nu mice with human colorectal tumor xenografts using 1-[2-fluoro-3-(2-nitroimidazol-1-yl)-propyl]-piperidine (F-PIMO): A novel PET imaging agent
    Sudha Garg, Richard Minton, Costas Koumenis, James Raleigh, David Lee, Xiaoshen Ji and Pradeep Garg
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 91P;
  • You have access
    Characterization of 131I-SKI243, a radiolabeled EGFR-tk binding ligand, and its cross reactivity for Iressa and Tarceva binding sites
    Peter Smith-Jones, Mohammad Namavari, Artie Glekas, Cindy Usher and Steve Larson
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 92P;
  • You have access
    EGFR receptor binding properties and internalization of copper-64-DOTA-C225 in five cervical cancer cell lines
    Martin Eiblmaier, Laura Meyer, Wen Li, Mark Watson, Linda Pike, Paula Fracasso and Carolyn Anderson
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 96P;
  • You have access
    Radioiodinated Heat Shock Protein 90 binding purine based ligands
    Peter Smith-Jones, Jacek Koziorowski, Cindy Usher, Danuta Zatoeska, Gabriela Chiosis and Steve Larson
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 91P;
  • You have access
    Characterization of prototype selective high affinity ligands (SHALs) serving as HLA-DR “antibody mimics” for lymphoma/leukemia imaging and therapy
    Gerald DeNardo, Saphon Hok, Arutselvan Natarajan, Laird Miers, Julie Perkins, Joerg Lehmann, Felice Lightstone, Monique Cosman, Sally DeNardo and Rodney Balhorn
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 93P;
  • You have access
    Novel use of azide and alkyne cycloaddition reaction for multifunctional scFv tumor pretargeting radiopharmaceuticals
    Arutselvan Natarajan, Wenjun Du, Cheng-Yi Xiong, Jacquelyn Gervay-Hague, Gerald De Nardo and Sally De Nardo
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 95P;
  • You have access
    64Cu-SarAr-antibody conjugates for PET imaging of neuroblastoma
    S Voss, A Packard, S Smith, N McIntosh, E Cyr, A Bonab, E Carter, A Fischman, S Treves and J Huston
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 96P;

Pages

  • Previous
  • Next
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
SNMMI

© 2025 SNMMI

Powered by HighWire